ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Lancets for Home Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-16C12589
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Lancets for Home Market Research Report 2022
BUY CHAPTERS

Global Diabetes Lancets for Home Market Research Report 2025

Code: QYRE-Auto-16C12589
Report
February 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
BD
Ascensia
LifeScan Inc
B. Braun
Terumo
Nipro
Cardinal Health
Arkray
ICU Medical
Owen Mumford
Hemocue AB
Greiner Bio One
HTL-Strefa
Sarstedt

Diabetes Lancets for Home Market Size

The global market for Diabetes Lancets for Home was valued at US$ 1161 million in the year 2024 and is projected to reach a revised size of US$ 1647 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Diabetes Lancets for Home Market

Diabetes Lancets for Home Market

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diabetes Lancets for Home, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Lancets for Home.
The Diabetes Lancets for Home market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Lancets for Home market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Lancets for Home manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Diabetes Lancets for Home Market Report

Report Metric Details
Report Name Diabetes Lancets for Home Market
Accounted market size in year US$ 1161 million
Forecasted market size in 2031 US$ 1647 million
CAGR 5.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, BD, Ascensia, Lifescan, B. Braun, Terumo, Nipro, Cardinal Health, ARKRAY, ICU Medical, Owen Mumford, HemoCue, Greiner Bio One, HTL-STREFA, Sarstedt
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diabetes Lancets for Home manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diabetes Lancets for Home in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Diabetes Lancets for Home Market growing?

Ans: The Diabetes Lancets for Home Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Diabetes Lancets for Home Market size in 2031?

Ans: The Diabetes Lancets for Home Market size in 2031 will be US$ 1647 million.

Who are the main players in the Diabetes Lancets for Home Market report?

Ans: The main players in the Diabetes Lancets for Home Market are Roche, BD, Ascensia, Lifescan, B. Braun, Terumo, Nipro, Cardinal Health, ARKRAY, ICU Medical, Owen Mumford, HemoCue, Greiner Bio One, HTL-STREFA, Sarstedt

What are the Application segmentation covered in the Diabetes Lancets for Home Market report?

Ans: The Applications covered in the Diabetes Lancets for Home Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Diabetes Lancets for Home Market report?

Ans: The Types covered in the Diabetes Lancets for Home Market report are Safety Lancets with Needle, Safety Lancets with Blade

Recommended Reports

Diabetes Home Testing

Blood Collection Devices

Diabetes Injection Devices

1 Diabetes Lancets for Home Market Overview
1.1 Product Definition
1.2 Diabetes Lancets for Home by Type
1.2.1 Global Diabetes Lancets for Home Market Value Comparison by Type (2024 VS 2031)
1.2.2 Safety Lancets with Needle
1.2.3 Safety Lancets with Blade
1.3 Diabetes Lancets for Home by Application
1.3.1 Global Diabetes Lancets for Home Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Diabetes Lancets for Home Market Size Estimates and Forecasts
1.4.1 Global Diabetes Lancets for Home Revenue 2020-2031
1.4.2 Global Diabetes Lancets for Home Sales 2020-2031
1.4.3 Global Diabetes Lancets for Home Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diabetes Lancets for Home Market Competition by Manufacturers
2.1 Global Diabetes Lancets for Home Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diabetes Lancets for Home Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diabetes Lancets for Home Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diabetes Lancets for Home, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetes Lancets for Home, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Lancets for Home, Product Type & Application
2.7 Global Key Manufacturers of Diabetes Lancets for Home, Date of Enter into This Industry
2.8 Global Diabetes Lancets for Home Market Competitive Situation and Trends
2.8.1 Global Diabetes Lancets for Home Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diabetes Lancets for Home Players Market Share by Revenue
2.8.3 Global Diabetes Lancets for Home Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diabetes Lancets for Home Market Scenario by Region
3.1 Global Diabetes Lancets for Home Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diabetes Lancets for Home Sales by Region: 2020-2031
3.2.1 Global Diabetes Lancets for Home Sales by Region: 2020-2025
3.2.2 Global Diabetes Lancets for Home Sales by Region: 2026-2031
3.3 Global Diabetes Lancets for Home Revenue by Region: 2020-2031
3.3.1 Global Diabetes Lancets for Home Revenue by Region: 2020-2025
3.3.2 Global Diabetes Lancets for Home Revenue by Region: 2026-2031
3.4 North America Diabetes Lancets for Home Market Facts & Figures by Country
3.4.1 North America Diabetes Lancets for Home Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diabetes Lancets for Home Sales by Country (2020-2031)
3.4.3 North America Diabetes Lancets for Home Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diabetes Lancets for Home Market Facts & Figures by Country
3.5.1 Europe Diabetes Lancets for Home Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diabetes Lancets for Home Sales by Country (2020-2031)
3.5.3 Europe Diabetes Lancets for Home Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Lancets for Home Market Facts & Figures by Region
3.6.1 Asia Pacific Diabetes Lancets for Home Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diabetes Lancets for Home Sales by Region (2020-2031)
3.6.3 Asia Pacific Diabetes Lancets for Home Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diabetes Lancets for Home Market Facts & Figures by Country
3.7.1 Latin America Diabetes Lancets for Home Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diabetes Lancets for Home Sales by Country (2020-2031)
3.7.3 Latin America Diabetes Lancets for Home Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Lancets for Home Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Lancets for Home Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diabetes Lancets for Home Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diabetes Lancets for Home Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetes Lancets for Home Sales by Type (2020-2031)
4.1.1 Global Diabetes Lancets for Home Sales by Type (2020-2025)
4.1.2 Global Diabetes Lancets for Home Sales by Type (2026-2031)
4.1.3 Global Diabetes Lancets for Home Sales Market Share by Type (2020-2031)
4.2 Global Diabetes Lancets for Home Revenue by Type (2020-2031)
4.2.1 Global Diabetes Lancets for Home Revenue by Type (2020-2025)
4.2.2 Global Diabetes Lancets for Home Revenue by Type (2026-2031)
4.2.3 Global Diabetes Lancets for Home Revenue Market Share by Type (2020-2031)
4.3 Global Diabetes Lancets for Home Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diabetes Lancets for Home Sales by Application (2020-2031)
5.1.1 Global Diabetes Lancets for Home Sales by Application (2020-2025)
5.1.2 Global Diabetes Lancets for Home Sales by Application (2026-2031)
5.1.3 Global Diabetes Lancets for Home Sales Market Share by Application (2020-2031)
5.2 Global Diabetes Lancets for Home Revenue by Application (2020-2031)
5.2.1 Global Diabetes Lancets for Home Revenue by Application (2020-2025)
5.2.2 Global Diabetes Lancets for Home Revenue by Application (2026-2031)
5.2.3 Global Diabetes Lancets for Home Revenue Market Share by Application (2020-2031)
5.3 Global Diabetes Lancets for Home Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Diabetes Lancets for Home Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BD Diabetes Lancets for Home Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Ascensia
6.3.1 Ascensia Company Information
6.3.2 Ascensia Description and Business Overview
6.3.3 Ascensia Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ascensia Diabetes Lancets for Home Product Portfolio
6.3.5 Ascensia Recent Developments/Updates
6.4 Lifescan
6.4.1 Lifescan Company Information
6.4.2 Lifescan Description and Business Overview
6.4.3 Lifescan Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lifescan Diabetes Lancets for Home Product Portfolio
6.4.5 Lifescan Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Company Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B. Braun Diabetes Lancets for Home Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Company Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo Diabetes Lancets for Home Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Nipro
6.7.1 Nipro Company Information
6.7.2 Nipro Description and Business Overview
6.7.3 Nipro Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nipro Diabetes Lancets for Home Product Portfolio
6.7.5 Nipro Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Company Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cardinal Health Diabetes Lancets for Home Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Company Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ARKRAY Diabetes Lancets for Home Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 ICU Medical
6.10.1 ICU Medical Company Information
6.10.2 ICU Medical Description and Business Overview
6.10.3 ICU Medical Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ICU Medical Diabetes Lancets for Home Product Portfolio
6.10.5 ICU Medical Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Company Information
6.11.2 Owen Mumford Description and Business Overview
6.11.3 Owen Mumford Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Owen Mumford Diabetes Lancets for Home Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 HemoCue
6.12.1 HemoCue Company Information
6.12.2 HemoCue Description and Business Overview
6.12.3 HemoCue Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.12.4 HemoCue Diabetes Lancets for Home Product Portfolio
6.12.5 HemoCue Recent Developments/Updates
6.13 Greiner Bio One
6.13.1 Greiner Bio One Company Information
6.13.2 Greiner Bio One Description and Business Overview
6.13.3 Greiner Bio One Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Greiner Bio One Diabetes Lancets for Home Product Portfolio
6.13.5 Greiner Bio One Recent Developments/Updates
6.14 HTL-STREFA
6.14.1 HTL-STREFA Company Information
6.14.2 HTL-STREFA Description and Business Overview
6.14.3 HTL-STREFA Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.14.4 HTL-STREFA Diabetes Lancets for Home Product Portfolio
6.14.5 HTL-STREFA Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Company Information
6.15.2 Sarstedt Description and Business Overview
6.15.3 Sarstedt Diabetes Lancets for Home Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sarstedt Diabetes Lancets for Home Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Lancets for Home Industry Chain Analysis
7.2 Diabetes Lancets for Home Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Lancets for Home Production Mode & Process Analysis
7.4 Diabetes Lancets for Home Sales and Marketing
7.4.1 Diabetes Lancets for Home Sales Channels
7.4.2 Diabetes Lancets for Home Distributors
7.5 Diabetes Lancets for Home Customer Analysis
8 Diabetes Lancets for Home Market Dynamics
8.1 Diabetes Lancets for Home Industry Trends
8.2 Diabetes Lancets for Home Market Drivers
8.3 Diabetes Lancets for Home Market Challenges
8.4 Diabetes Lancets for Home Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
BD
Ascensia
LifeScan Inc
B. Braun
Terumo
Nipro
Cardinal Health
Arkray
ICU Medical
Owen Mumford
Hemocue AB
Greiner Bio One
HTL-Strefa
Sarstedt
List of Tables
 Table 1. Global Diabetes Lancets for Home Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Diabetes Lancets for Home Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Diabetes Lancets for Home Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Diabetes Lancets for Home Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Diabetes Lancets for Home Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Diabetes Lancets for Home Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Diabetes Lancets for Home Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Diabetes Lancets for Home Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Diabetes Lancets for Home, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Diabetes Lancets for Home, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Diabetes Lancets for Home, Product Type & Application
 Table 12. Global Key Manufacturers of Diabetes Lancets for Home, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Diabetes Lancets for Home by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Lancets for Home as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diabetes Lancets for Home Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Diabetes Lancets for Home Sales by Region (2020-2025) & (K Units)
 Table 18. Global Diabetes Lancets for Home Sales Market Share by Region (2020-2025)
 Table 19. Global Diabetes Lancets for Home Sales by Region (2026-2031) & (K Units)
 Table 20. Global Diabetes Lancets for Home Sales Market Share by Region (2026-2031)
 Table 21. Global Diabetes Lancets for Home Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Diabetes Lancets for Home Revenue Market Share by Region (2020-2025)
 Table 23. Global Diabetes Lancets for Home Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Diabetes Lancets for Home Revenue Market Share by Region (2026-2031)
 Table 25. North America Diabetes Lancets for Home Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Diabetes Lancets for Home Sales by Country (2020-2025) & (K Units)
 Table 27. North America Diabetes Lancets for Home Sales by Country (2026-2031) & (K Units)
 Table 28. North America Diabetes Lancets for Home Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Diabetes Lancets for Home Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Diabetes Lancets for Home Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Diabetes Lancets for Home Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Diabetes Lancets for Home Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Diabetes Lancets for Home Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Diabetes Lancets for Home Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Diabetes Lancets for Home Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Diabetes Lancets for Home Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Diabetes Lancets for Home Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Diabetes Lancets for Home Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Diabetes Lancets for Home Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Diabetes Lancets for Home Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Diabetes Lancets for Home Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Diabetes Lancets for Home Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Diabetes Lancets for Home Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Diabetes Lancets for Home Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Diabetes Lancets for Home Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Diabetes Lancets for Home Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Diabetes Lancets for Home Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Diabetes Lancets for Home Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Diabetes Lancets for Home Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Diabetes Lancets for Home Sales (K Units) by Type (2020-2025)
 Table 51. Global Diabetes Lancets for Home Sales (K Units) by Type (2026-2031)
 Table 52. Global Diabetes Lancets for Home Sales Market Share by Type (2020-2025)
 Table 53. Global Diabetes Lancets for Home Sales Market Share by Type (2026-2031)
 Table 54. Global Diabetes Lancets for Home Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Diabetes Lancets for Home Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Diabetes Lancets for Home Revenue Market Share by Type (2020-2025)
 Table 57. Global Diabetes Lancets for Home Revenue Market Share by Type (2026-2031)
 Table 58. Global Diabetes Lancets for Home Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Diabetes Lancets for Home Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Diabetes Lancets for Home Sales (K Units) by Application (2020-2025)
 Table 61. Global Diabetes Lancets for Home Sales (K Units) by Application (2026-2031)
 Table 62. Global Diabetes Lancets for Home Sales Market Share by Application (2020-2025)
 Table 63. Global Diabetes Lancets for Home Sales Market Share by Application (2026-2031)
 Table 64. Global Diabetes Lancets for Home Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Diabetes Lancets for Home Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Diabetes Lancets for Home Revenue Market Share by Application (2020-2025)
 Table 67. Global Diabetes Lancets for Home Revenue Market Share by Application (2026-2031)
 Table 68. Global Diabetes Lancets for Home Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Diabetes Lancets for Home Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Diabetes Lancets for Home Product
 Table 74. Roche Recent Developments/Updates
 Table 75. BD Company Information
 Table 76. BD Description and Business Overview
 Table 77. BD Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BD Diabetes Lancets for Home Product
 Table 79. BD Recent Developments/Updates
 Table 80. Ascensia Company Information
 Table 81. Ascensia Description and Business Overview
 Table 82. Ascensia Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ascensia Diabetes Lancets for Home Product
 Table 84. Ascensia Recent Developments/Updates
 Table 85. Lifescan Company Information
 Table 86. Lifescan Description and Business Overview
 Table 87. Lifescan Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lifescan Diabetes Lancets for Home Product
 Table 89. Lifescan Recent Developments/Updates
 Table 90. B. Braun Company Information
 Table 91. B. Braun Description and Business Overview
 Table 92. B. Braun Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. B. Braun Diabetes Lancets for Home Product
 Table 94. B. Braun Recent Developments/Updates
 Table 95. Terumo Company Information
 Table 96. Terumo Description and Business Overview
 Table 97. Terumo Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Terumo Diabetes Lancets for Home Product
 Table 99. Terumo Recent Developments/Updates
 Table 100. Nipro Company Information
 Table 101. Nipro Description and Business Overview
 Table 102. Nipro Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Nipro Diabetes Lancets for Home Product
 Table 104. Nipro Recent Developments/Updates
 Table 105. Cardinal Health Company Information
 Table 106. Cardinal Health Description and Business Overview
 Table 107. Cardinal Health Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cardinal Health Diabetes Lancets for Home Product
 Table 109. Cardinal Health Recent Developments/Updates
 Table 110. ARKRAY Company Information
 Table 111. ARKRAY Description and Business Overview
 Table 112. ARKRAY Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. ARKRAY Diabetes Lancets for Home Product
 Table 114. ARKRAY Recent Developments/Updates
 Table 115. ICU Medical Company Information
 Table 116. ICU Medical Description and Business Overview
 Table 117. ICU Medical Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. ICU Medical Diabetes Lancets for Home Product
 Table 119. ICU Medical Recent Developments/Updates
 Table 120. Owen Mumford Company Information
 Table 121. Owen Mumford Description and Business Overview
 Table 122. Owen Mumford Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Owen Mumford Diabetes Lancets for Home Product
 Table 124. Owen Mumford Recent Developments/Updates
 Table 125. HemoCue Company Information
 Table 126. HemoCue Description and Business Overview
 Table 127. HemoCue Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. HemoCue Diabetes Lancets for Home Product
 Table 129. HemoCue Recent Developments/Updates
 Table 130. Greiner Bio One Company Information
 Table 131. Greiner Bio One Description and Business Overview
 Table 132. Greiner Bio One Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Greiner Bio One Diabetes Lancets for Home Product
 Table 134. Greiner Bio One Recent Developments/Updates
 Table 135. HTL-STREFA Company Information
 Table 136. HTL-STREFA Description and Business Overview
 Table 137. HTL-STREFA Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. HTL-STREFA Diabetes Lancets for Home Product
 Table 139. HTL-STREFA Recent Developments/Updates
 Table 140. Sarstedt Company Information
 Table 141. Sarstedt Description and Business Overview
 Table 142. Sarstedt Diabetes Lancets for Home Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Sarstedt Diabetes Lancets for Home Product
 Table 144. Sarstedt Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Diabetes Lancets for Home Distributors List
 Table 148. Diabetes Lancets for Home Customers List
 Table 149. Diabetes Lancets for Home Market Trends
 Table 150. Diabetes Lancets for Home Market Drivers
 Table 151. Diabetes Lancets for Home Market Challenges
 Table 152. Diabetes Lancets for Home Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Diabetes Lancets for Home
 Figure 2. Global Diabetes Lancets for Home Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diabetes Lancets for Home Market Share by Type: 2024 & 2031
 Figure 4. Safety Lancets with Needle Product Picture
 Figure 5. Safety Lancets with Blade Product Picture
 Figure 6. Global Diabetes Lancets for Home Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Diabetes Lancets for Home Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Retail Pharmacy
 Figure 10. Other
 Figure 11. Global Diabetes Lancets for Home Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Diabetes Lancets for Home Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Diabetes Lancets for Home Sales (2020-2031) & (K Units)
 Figure 14. Global Diabetes Lancets for Home Average Price (US$/Unit) & (2020-2031)
 Figure 15. Diabetes Lancets for Home Report Years Considered
 Figure 16. Diabetes Lancets for Home Sales Share by Manufacturers in 2024
 Figure 17. Global Diabetes Lancets for Home Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Diabetes Lancets for Home Players: Market Share by Revenue in Diabetes Lancets for Home in 2024
 Figure 19. Diabetes Lancets for Home Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Diabetes Lancets for Home Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Diabetes Lancets for Home Sales Market Share by Country (2020-2031)
 Figure 22. North America Diabetes Lancets for Home Revenue Market Share by Country (2020-2031)
 Figure 23. United States Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Diabetes Lancets for Home Sales Market Share by Country (2020-2031)
 Figure 26. Europe Diabetes Lancets for Home Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Diabetes Lancets for Home Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Diabetes Lancets for Home Revenue Market Share by Region (2020-2031)
 Figure 34. China Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Diabetes Lancets for Home Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Diabetes Lancets for Home Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Diabetes Lancets for Home Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Diabetes Lancets for Home Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Diabetes Lancets for Home Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Diabetes Lancets for Home by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Diabetes Lancets for Home by Type (2020-2031)
 Figure 53. Global Diabetes Lancets for Home Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Diabetes Lancets for Home by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Diabetes Lancets for Home by Application (2020-2031)
 Figure 56. Global Diabetes Lancets for Home Price (US$/Unit) by Application (2020-2031)
 Figure 57. Diabetes Lancets for Home Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Medical Blood Lancet Market Research Report 2025
Global Lancets Market Research Report 2024
Global Skin Puncture Lancet Market Research Report 2025
Global Blood Micro sampling Medical Devices Market Research Report 2025
Global Safety Skin Puncture Lancet Market Research Report 2025
Global Capillary Blood Collection Lancet Market Research Report 2025
Global Standard Lancets Market Insights Forecast to 2030
Global Blood Glucose Lancets Market Research Report 2024
Global Disposable Diabetes Lancets Market Research Report 2024
Global Lancet Pens and Needles Market Research Report 2024
Global Safety Lancets for Diabetes Market Research Report 2025
Global Blood Sugar Lancets Market Research Report 2024
Global Disposable Lancets Market Research Report 2024
Diabetes Lancing Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile Lancets Market Research Report 2024
Global Diabetic Lancet Device Market Research Report 2024
Global Medical Disposable Lancet Market Research Report 2024
Global Sterile Disposable Lancets Market Research Report 2024
Global Pricking Needle Market Research Report 2025
Global Disposable Sterile Lancets Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions